InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Adams Kendra, 首席财务官. Director active across 1 company, notably C4 Therapeutics, Inc.. Cumulatively, 12 filings have been recorded. Activity tracked since 18 September 2023. The latest transaction was disclosed on 13 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Adams Kendra
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
240,000 股0Common StockSEC:0001470831-26-000175:0
6,250 股0Common StockSEC:0001470831-25-000223:0
1,863 股@ US$3.2012.0% 占其流量Common StockSEC:0001662579-25-000016:0
4,559 股@ US$3.1828.9% 占其流量Common StockSEC:0001662579-25-000016:2
87,100 股0Common StockSEC:0001662579-25-000016:1
3,750 股Common StockSEC:0001662579-24-000103:0
1,102 股@ US$6.0412.9% 占其流量Common StockSEC:0001662579-24-000103:1
1,837 股@ US$6.3822.0% 占其流量Common StockSEC:0001662579-24-000086:0
661 股@ US$6.367.9% 占其流量Common StockSEC:0001662579-24-000082:1
2,250 股Common StockSEC:0001662579-24-000082:0
1,301 股@ US$6.5316.4% 占其流量Common StockSEC:0001662579-24-000014:0
25,000 股0Common StockSEC:0001662579-23-000097:0
12 条申报中的 12 条
About Adams Kendra
Adams Kendra is the Chief Financial Officer at C4 Therapeutics, Inc. In this role, she is responsible for the company's financial management, including budgeting and financial analysis. Her expertise is crucial in ensuring the financial health of the organization.
